2023
DOI: 10.1007/s00296-023-05360-z
|View full text |Cite
|
Sign up to set email alerts
|

Stepwise asynchronous telehealth assessment of patients with suspected axial spondyloarthritis: results from a pilot study

Labinsky Hannah,
Rohr von Sophie,
Raimondo Maria Gabriella
et al.

Abstract: Patients with axial spondyloarthritis (axSpA) suffer from one of the longest diagnostic delays among all rheumatic diseases. Telemedicine (TM) may reduce this diagnostic delay by providing easy access to care. Diagnostic rheumatology telehealth studies are scarce and largely limited to traditional synchronous approaches such as resource-intensive video and telephone consultations. The aim of this study was to investigate a stepwise asynchronous telemedicine-based diagnostic approach in patients with suspected … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 29 publications
0
1
0
Order By: Relevance
“…Studies on telehealth in rheumatology focus on video and phone consultations [ 25 ]. The asynchronous physician-based telemedicine approach to diagnose AxSpA with access to imaging results may be helpful for correct diagnosis [ 26 ].…”
Section: Discussionmentioning
confidence: 99%
“…Studies on telehealth in rheumatology focus on video and phone consultations [ 25 ]. The asynchronous physician-based telemedicine approach to diagnose AxSpA with access to imaging results may be helpful for correct diagnosis [ 26 ].…”
Section: Discussionmentioning
confidence: 99%
“…Utilizing asynchronous telemedicine solutions can effectively address this issue. Obtaining radiologic images is crucial at this juncture [ 114 ]. Integrating electronic patient-reported outcomes allows for remote and standardized evaluation of treatment effectiveness and rapid modifications to the treatment plan.…”
Section: Telehealthmentioning
confidence: 99%
“…To assess the benefits and potential risks of apps, a robust assessment is essential and must consider the entire lifecycle of mobile medical apps, including design, development, deployment and postmarket surveillance. 29 While the exact assessment and criteria differ between the jurisdictions (USA, EU, UK) and specific process (primary regulatory approval, medical guidelines, reimbursement), key dimensions of assessment are universally present and include: ► Clinical validity and efficacy: digital health apps must be evaluated for their clinical validity (whether the app's measurements and outcomes are reliable) and efficacy, supported by scientific evidence and adherence to relevant clinical guidelines. Clinical trials and real-world data analysis are crucial in establishing the effectiveness of these apps.…”
Section: Accessibilitymentioning
confidence: 99%
“…To assess the benefits and potential risks of apps, a robust assessment is essential and must consider the entire lifecycle of mobile medical apps, including design, development, deployment and postmarket surveillance. 29 While the exact assessment and criteria differ between the jurisdictions (USA, EU, UK) and specific process (primary regulatory approval, medical guidelines, reimbursement), key dimensions of assessment are universally present and include:…”
Section: Introductionmentioning
confidence: 99%